Iterum Therapeutics (ITRM) PT Lowered to $8 at RBC Capital
Tweet
Share
E-mailGet Alerts ITRM Hot Sheet
Price: $0.03 --0%
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
RBC Capital analyst Gregory Renza lowered the price target on Iterum Therapeutics (NASDAQ: ITRM) to $8.00 (from $10.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Freedom Broker Downgrades Workday (WDAY) to Hold
- Nomura/Instinet Upgrades Malayan Banking Bhd (MAY:MK) to Buy
- Minimax Group Inc (100:HK) PT Raised to HK$804 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
